1346773-63-4 Usage
General Description
(R)-tert-butyl 5-oxopyrrolidin-3-ylcarbaMate is a chemical compound with the molecular formula C11H19NO3. It is a carbamate derivative of pyrrolidine, a heterocyclic organic compound. This chemical is an enantiomer of tert-butyl 5-oxopyrrolidin-3-ylcarbamate and is often used as a building block in organic synthesis. It is commonly employed in the pharmaceutical and agrochemical industries as a key intermediate in the production of various biologically active compounds. The presence of the tert-butyl group contributes to its stability and selectivity in chemical reactions, making it a valuable tool in the development of new pharmaceuticals and agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1346773-63-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,7,7 and 3 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1346773-63:
(9*1)+(8*3)+(7*4)+(6*6)+(5*7)+(4*7)+(3*3)+(2*6)+(1*3)=184
184 % 10 = 4
So 1346773-63-4 is a valid CAS Registry Number.
1346773-63-4Relevant articles and documents
POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR
-
Paragraph 1328-1330, (2018/11/21)
The present application relates to positive allosteric modulators of the muscarinic M2 receptor, especially to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, in particular for treatment and/or prevention of cardiovascular disorders and/or renal disorders.
NEW HETEROCYCLIC AMIDE COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
Page 45-46, (2010/11/30)
The present invention relates to novel heterocyclic compounds that inhibit phosphodiesterase type 4 (PDE 4). The compounds are useful for treating inflammatory conditions, diseases of the central nervous systems and insulin resistant diabetes.
